Trial intelligence / Profile preview

HKT-500 for Pain in Ankle Sprain

NCT00927641Phase 3Completed

Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Start
Jul 2009
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Ankle sprain comparing Ketoprofen Patch with Placebo Patch (2 arms). Primary endpoint: Change from baseline of the 100-mm VAS pain intensity score during monopodal weight bearing at Day 4. Started Jul 2009; status: completed.

02

Drugs

Ketofen
03

Conditions

Ankle sprain

Beyond the preview

Go deeper on NCT00927641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00927641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call